11h
Gene Editing Has Struggled To Go Commercial. This Nobel Laureate Has A $1 Billion Plan To Fix That.
Crispr’s ability to cut genetic code like scissors has just started to turn into medicines. Now, gene editing pioneer ...
RIT researchers solve multiple tissue engineering challenges by developing a novel hydrogel to host human cells and a device to 3D print bioinks safely.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results